A study protocol of a single-arm, prospective, open-label, non-controlled, phase II study of neoadjuvant BL-B01D1 combined with aumolertinib in resectable stage II–IIIB non-small cell lung cancer patients with EGFR mutation
Yue Chen, Jiandong Mei, Ge Gao, Benxia Zhang et autres
cn (code pays fourni par la source)
1 citation
Translational Lung Cancer Research